palonosetron intravenous / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
palonosetron intravenous / Generic mfg.
2006-002935-25: multicenter phase II study to evaluate palonosetron +desametasone in the prevention of nausea and vomiting in patientes resected for colon cancer and treated with moderate emetogenus chemotherapy.

Ongoing
2
81
Europe
LEDERFOLIN*EV 1FL LIOF 175MG, FLUOROURACILE TEVA*IV FL 5G, ELOXATIN*IV 1FL POLV 100MG, ALOXI*1FL 250MCG 5ML, SOLDESAM*INIET 3F 1ML 4MG, LEDERFOLIN*EV 1FL LIOF 175MG, FLUOROURACILE TEVA*IV FL 5G, ELOXATIN*IV 1FL POLV 100MG, ALOXI*1FL 250MCG 5ML, SOLDESAM*INIET 3F 1ML 4MG
GOIM GRUPPO ONCOLOGICO MERIDIONALE
patientes resected for colon cancer and treated with moderate emetogenus
 
 

Download Options